3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Somatoform Disorders
1
Neoplasms
1
Nausea
1
Multiple Myeloma
1
Breast Neoplasms
1
Interventions
Aprepitant
8
Palonosetron
6
Dexamethasone
6
Granisetron
3
fosaprepitant
2
dexamethasone 21-phosphate
2
Tropisetron
2
Ondansetron
2
Metoclopramide
2
Calcium Dobesilate
2
ramosetron
1
naldemedine
1
gamma-Aminobutyric Acid
1
dolasetron
1
dexamethasone acetate
1
alizapride
1
Tablets
1
Spinal Puncture
1
Saline Solution
1
Population Groups
1
Olanzapine
1
Myelography
1
Duration of Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Vomiting
×
dexamethasone acetate
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts